UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED® lamp

British journal of dermatology (1951), 2016-10, Vol.175 (4), p.696-705

2016

Volltextzugriff (PDF)

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

The New England journal of medicine, 2019-10, Vol.381 (16), p.1524-1534

2019

Volltextzugriff (PDF)

Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy

PloS one, 2017-08, Vol.12 (8), p.e0183845-e0183845

2017

Volltextzugriff (PDF)

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Blood, 2017-12, Vol.130 (23), p.2499-2503

2017

Volltextzugriff (PDF)

Granulomatosis with polyangiitis presents with skip lesions of the bowel

The Lancet (British edition), 2021-07, Vol.398 (10298), p.e8-e8

2021

Volltextzugriff (PDF)

Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation

PloS one, 2016-06, Vol.11 (6), p.e0156693-e0156693

2016

Volltextzugriff (PDF)

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

The Lancet. Haematology, 2017-12, Vol.4 (12), p.e595-e606

2017

Volltextzugriff (PDF)

The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis

The Journal of infection, 2019-05, Vol.78 (5), p.339-348

2019

Volltextzugriff (PDF)

A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial

Trials, 2020-10, Vol.21 (1), p.828-828, Article 828

2020

Volltextzugriff (PDF)

UGT2B17 modifies drug response in chronic lymphocytic leukaemia

British journal of cancer, 2020-07, Vol.123 (2), p.240-251

2020

Volltextzugriff (PDF)

Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL

Cells (Basel, Switzerland), 2020-06, Vol.9 (6), p.1484

2020

Volltextzugriff (PDF)

Incidence and risk factors for umbilical incisional hernia after reduced port colorectal surgery (SIL + 1 additional port)—is an umbilical midline approach really a problem?

Langenbeck's archives of surgery, 2022-05, Vol.407 (3), p.1241-1249

2022

Volltextzugriff (PDF)

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study

Breast cancer research and treatment, 2017-01, Vol.161 (1), p.63-72

2017

Volltextzugriff (PDF)

The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

Strahlentherapie und Onkologie, 2018-11, Vol.194 (11), p.991-1006

2018

Volltextzugriff (PDF)

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

The Lancet. Haematology, 2021-05, Vol.8 (5), p.e355-e364

2021

Volltextzugriff (PDF)

High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer –Results from a prospective pilot study using a 37 gene panel

Urologic oncology, 2020-07, Vol.38 (7), p.637.e17-637.e27

2020

Volltextzugriff (PDF)

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30‐positive aggressive lymphomas

European journal of haematology, 2020-03, Vol.104 (3), p.251-258

2020

Volltextzugriff (PDF)

Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer

Clinical cancer research, 2006-05, Vol.12 (10), p.3085-3091

2006

Volltextzugriff (PDF)

Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer

Urologic oncology, 2022-01, Vol.40 (1), p.8.e11-8.e18

2022

Volltextzugriff (PDF)

Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals

Nature genetics, 2018-08, Vol.50 (8), p.1112-1121

2018

Volltextzugriff (PDF)

Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma

Leukemia & lymphoma, 2016-08, Vol.57 (8), p.1831-1838

2016

Volltextzugriff (PDF)

Roles of human β-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells

Histochemistry and cell biology, 2010-07, Vol.134 (1), p.59-73

2010

Volltextzugriff (PDF)

Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study

BMC cancer, 2013-06, Vol.13 (1), p.272-272, Article 272

2013

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Science & Technology
(26)
Life Sciences & Biomedicine
(24)
Male
(24)
Female
(23)
Aged
(22)
Adult
(20)
Aged, 80 And Over
(11)
Oncology
(10)
Treatment Outcome
(9)
Young Adult
(7)
Hematology
(6)
Chemotherapy
(5)
Medicine
(5)
Prognosis
(5)
Adolescent
(4)
Antineoplastic Agents - Therapeutic Use
(4)
Medicine & Public Health
(4)
Analysis
(3)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED® lamp

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Granulomatosis with polyangiitis presents with skip lesions of the bowel

Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis

A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial

UGT2B17 modifies drug response in chronic lymphocytic leukaemia

Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL

Incidence and risk factors for umbilical incisional hernia after reduced port colorectal surgery (SIL + 1 additional port)—is an umbilical midline approach really a problem?

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study

The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer –Results from a prospective pilot study using a 37 gene panel

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30‐positive aggressive lymphomas

Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer

Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer

Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study

Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals

Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma

Roles of human β-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells

Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study

Aktive Filter

Suchergebnisse filtern